000			01361 a2200361 4500
005			20250513112604.0
264		0	_c19970321
008			199703s 0 0 eng d
022			_a0014-2980
024	7		_a10.1002/eji.1830270203 _2doi
040			_aNLM _beng _cNLM
100	1		_aCarson, W E
245	0	0	_aCD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand. _h[electronic resource]
260			_bEuropean journal of immunology _cFeb 1997
300			_a354-60 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdenocarcinoma
650	0	4	_aAnimals
650	0	4	_aCD56 Antigen _xanalysis
650	0	4	_aHumans
650	0	4	_aInterleukin-2 _xpharmacology
650	0	4	_aKiller Cells, Lymphokine-Activated _xdrug effects
650	0	4	_aKiller Cells, Natural _xdrug effects
650	0	4	_aMast-Cell Sarcoma
650	0	4	_aMice
650	0	4	_aReceptors, IgG _xanalysis
650	0	4	_aStem Cell Factor _xpharmacology
650	0	4	_aTumor Cells, Cultured
700	1		_aFehniger, T A
700	1		_aCaligiuri, M A
773	0		_tEuropean journal of immunology _gvol. 27 _gno. 2 _gp. 354-60
856	4	0	_uhttps://doi.org/10.1002/eji.1830270203 _zAvailable from publisher's website
999			_c9034356 _d9034356